๎
๎ผ
๎
BioLife Solutions Inc
BLFS24.900USD
-0.510-2.01%
์ข
๊ฐย 12/26, 16:00๏ผET๏ผ์์ธ๋ 15๋ถ ์ง์ฐ๋ฉ๋๋ค
1.19B์๊ฐ์ด์ก
์์คP/E TTM
๎
์์ธํ ๋ด์ฉ์ BioLife Solutions Inc ํ์ฌ
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Companyโs ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
BioLife Solutions Inc ์ ๋ณด
๎์ข
๋ชฉ ์ฝ๋ BLFS
ํ์ฌ ์ด๋ฆBioLife Solutions Inc
์์ฅ์ผNov 22, 1989
CEODe Greef (Roderick)
์ง์ ์159
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃNov 22
์ฃผ์Suite 310
๋์BOTHELL
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ98021
์ ํ14254011400
์น์ฌ์ดํธhttps://www.biolifesolutions.com/
์ข
๋ชฉ ์ฝ๋ BLFS
์์ฅ์ผNov 22, 1989
CEODe Greef (Roderick)
BioLife Solutions Inc์ ํ์ฌ ์์์ง
๎์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-7.30%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-0.42%
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
13.81K
-42.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
๋ ๋ณด๊ธฐ
์ด๋ฆ
์ด๋ฆ/์ง์
์ง์
์ฃผ์ ๋ณด์
๋ณ๋
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
252.89K
-0.21%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
150.11K
-0.28%
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
98.49K
-0.31%
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
81.02K
-31.81%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
68.75K
-30.38%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
49.99K
-0.43%
์์ต ๋ถ์
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
ํตํ: USD๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
๊ธฐ์
์ด ์์ง ๊ด๋ จ ๋ฐ์ดํฐ๋ฅผ ๊ณต๊ฐํ์ง ์์์ต๋๋ค.
์ฌ์
๋ณ
์ง์ญ๋ณ
์ฌ์
๋ณUSD
์ด๋ฆ
์์ต
๋น์จ
Product Revenue-Cell processing
22.90M
90.08%
Rental Revenue- Evo and thaw
1.68M
6.59%
Product Revenue- Evo and thaw
811.00K
3.19%
Service Revenue-Evo and thaw
36.00K
0.14%
์ฃผ์ ๋ณด์ ํต๊ณ
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Nov 15
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Nov 15
์ฃผ์ฃผ
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
๊ธฐํ
55.21%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น์จ
Casdin Capital, LLC
12.37%
BlackRock Institutional Trust Company, N.A.
10.60%
T. Rowe Price Investment Management, Inc.
8.45%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.15%
๊ธฐํ
55.21%
์ฃผ์ฃผ ์ ํ
์ฃผ์ฃผ
๋น์จ
Investment Advisor
49.20%
Investment Advisor/Hedge Fund
34.12%
Hedge Fund
15.54%
Research Firm
2.32%
Individual Investor
2.00%
Pension Fund
1.60%
Bank and Trust
0.65%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%
๊ธฐ๊ด ์ฃผ์ ๋ณด์
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Dec 8
๋ง์ง๋ง ์
๋ฐ์ดํธ: Mon, Dec 8
๋ณด๊ณ ๊ธฐ๊ฐ
๊ธฐ๊ด ์
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
2025Q4
402
49.86M
109.33%
-743.44K
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
๋ ๋ณด๊ธฐ
์ฃผ์ฃผ ํ๋
๎์ด๋ฆ
๋ณด์ ์ฃผ์
๋น์จ
๋ณ๋
Chg %
๋ ์ง
Casdin Capital, LLC
6.71M
14%
-1.00M
-12.97%
Aug 15, 2025
BlackRock Institutional Trust Company, N.A.
5.08M
10.61%
+12.43K
+0.25%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
4.25M
8.86%
+2.90M
+215.04%
Jun 30, 2025
Invesco Advisers, Inc.
3.46M
7.22%
+126.62K
+3.80%
Jun 30, 2025
The Vanguard Group, Inc.
2.89M
6.03%
+93.13K
+3.33%
Jun 30, 2025
State Street Investment Management (US)
1.41M
2.94%
-24.84K
-1.73%
Jun 30, 2025
Fred Alger Management, LLC
1.25M
2.61%
-285.09K
-18.60%
Jun 30, 2025
MFS Investment Management
1.10M
2.3%
+337.42K
+44.13%
Jun 30, 2025
Rockefeller Capital Management
1.03M
2.14%
+62.16K
+6.45%
Jun 30, 2025
๋ ๋ณด๊ธฐ
๊ด๋ จ ETF
๎๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
๋ง์ง๋ง ์
๋ฐ์ดํธ: Sat, Dec 6
์ด๋ฆ
๋น์จ
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
๋ ๋ณด๊ธฐ
Invesco S&P SmallCap Health Care ETF
๋น์จ0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
๋น์จ0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
๋น์จ0.52%
Zacks Small/Mid Cap ETF
๋น์จ0.41%
iShares Micro-Cap ETF
๋น์จ0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
๋น์จ0.15%
First Trust Small Cap Growth AlphaDEX Fund
๋น์จ0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
๋น์จ0.14%
iShares S&P Small-Cap 600 Growth ETF
๋น์จ0.14%
iShares ESG Select Screened S&P Small-Cap ETF
๋น์จ0.09%
์ฃผ์ ๋ฐฐ๋น๊ธ
๎์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.
๋ ์ง
๋ฐฐ๋น๊ธ
๊ธฐ์ค์ผ
์ง๊ธ์ผ
๋ฐฐ๋น๋ฝ์ผ
๋ฐ์ดํฐ ์์
์ฃผ์ ๋ถํ
๎๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
๋ ์ง
์ ํ
๋น์จ
๋ฐ์ดํฐ ์์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
BioLife Solutions Inc์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋๊ตฌ์ธ๊ฐ์?
๎BioLife Solutions Inc์ ์์ 5๋ ์ฃผ์ฃผ๋ ๋ค์๊ณผ ๊ฐ์ต๋๋ค:
Casdin Capital, LLC๋ 6.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 14.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 5.08M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 10.61%๋ฅผ ์ฐจ์งํฉ๋๋ค.
T. Rowe Price Investment Management, Inc.๋ 4.25M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 8.86%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Invesco Advisers, Inc.๋ 3.46M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 7.22%๋ฅผ ์ฐจ์งํฉ๋๋ค.
The Vanguard Group, Inc.๋ 2.89M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.03%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Casdin Capital, LLC๋ 6.71M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 14.00%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BlackRock Institutional Trust Company, N.A.๋ 5.08M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 10.61%๋ฅผ ์ฐจ์งํฉ๋๋ค.
T. Rowe Price Investment Management, Inc.๋ 4.25M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 8.86%๋ฅผ ์ฐจ์งํฉ๋๋ค.
Invesco Advisers, Inc.๋ 3.46M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 7.22%๋ฅผ ์ฐจ์งํฉ๋๋ค.
The Vanguard Group, Inc.๋ 2.89M์ฃผ์ ์ฃผ์์ ๋ณด์ ํ๊ณ ์์ผ๋ฉฐ, ์ ์ฒด ์ฃผ์์ 6.03%๋ฅผ ์ฐจ์งํฉ๋๋ค.
BioLife Solutions Inc์ ์์ 3๋ ์ฃผ์ฃผ ์ ํ์ ๋ฌด์์ธ๊ฐ์?
๎BioLife Solutions Inc์ ์ฃผ์ ์ฃผ์ฃผ ์ ํ ์์ 3๊ฐ์ง๋
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.์ ๋๋ค.
Casdin Capital, LLC
BlackRock Institutional Trust Company, N.A.
T. Rowe Price Investment Management, Inc.์ ๋๋ค.
BioLife Solutions Inc(BLFS)์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ๋ช ๊ฐ์ ๋๊น?
๎2025Q4 ๊ธฐ์ค์ผ๋ก, BioLife Solutions Inc์ ์ฃผ์์ ๋ณด์ ํ ๊ธฐ๊ด์ ์ด 402๊ณณ์ด๋ฉฐ, ์ด๋ค์ด ๋ณด์ ํ ์ฃผ์์ ์ด ๊ฐ์น๋ ์ฝ 49.86M๋ก ์ ์ฒด ๋ฐํ ์ฃผ์์ 109.33%๋ฅผ ์ฐจ์งํฉ๋๋ค. ์ด๋ 2025Q3 ๋๋น -3.40% ์ฆ๊ฐํ ์์น์
๋๋ค.
BioLife Solutions Inc์ ์ต๋ ์์ต์์ ๋ฌด์์ธ๊ฐ์?
๎FY2025Q2 ๊ธฐ์ค, BioLife Solutions Inc์ Product Revenue-Cell processing ๋ถ๋ฌธ์ด ๊ฐ์ฅ ๋์ ๋งค์ถ์ ๊ธฐ๋กํ์ผ๋ฉฐ, ๊ธ์ก์ 22.90M๋ก ์ ์ฒด ๋งค์ถ์ 90.08%๋ฅผ ์ฐจ์งํ์ต๋๋ค.
